View gallery.When the market gets a little sketchy, investors might tend to prefer the “blue chip” companies vs. the smaller companies due to the perceived safety in the bigger names.To isolate those bigger names, the most common method is by searching for companies with the largest market capitalization.Market cap is defined as the total dollar market value of all of […]
A doubling of Gilead Sciences ‘ sales has given investors plenty of reason to cheer on the biotech Goliath over the past year. However, with Gilead Sciences’ sales growth set to slow this year, investors may find that these three top biotech stocks prove to be a better bet in 2015.Source: Biogen Idec: Gilead Sciences’ slowing sales growth this year […]
Some well-known biotechnology exchange traded funds could be stirred by Gilead Sciences (GILD) fourth-quarter earnings report released Tuesday after the close of U.S. markets.The California-based company posted net income of $3.49 billion, or $2.18 a share, compared with $791 million, or 47 cents a share, a year earlier as revenue more than doubled to $7.31 billion from $3.12 billion on […]
It’s been shown that dividend-paying stocks outperform their non-dividend paying counterparts, but focusing on dividends may not be the best strategy when it comes to big biotech stocks. Read on to learn why three Motley Fool contributors don’t think it makes sense for these big biotech companies to pay investors a dividend.Cheryl Swanson : Take a little trip through history […]
View gallery.Biotech is big, and the industry has been big for quite some time.As a matter of fact, biotechnology has been the second-best performing industry over the last two years.Biotech stocks obviously come in all different shapes and sizes. Some investors like the small-caps, others prefer the middle of the road mid-caps.However, at the end of the day, the big […]
Watch tonight’s video market recap on my Ticker.tv channel, Mark333.Indexes continued their rotten start to 2015 as the S&P 500 fell 0.89% and the NASDAQ 1.29%. Markets opened up and then sellers came in which is not the type of action you want to see during a bull market move – you want the opposite (morning weakness bought!). Oil continues […]
SummaryThere has definitely been a sector rotation out of biotech stocks and into the consumer goods names that pay high dividend yields.
Amgen remains fairly valued based on 2015 earnings estimates.
The dividend is small but investors received a 29.5% increase to the dividend in the next quarter.
The last time I analyzed Amgen Inc. (NASDAQ:AMGN) on November 25, 2014, I stated, “More […]
NASDAQ had a good surge last week, but now people are honestly wondering what’s next. It had a nice pop at the open yesterday,, but immediately headed south and stayed there for the rest of the session. The bad news was that there was no enthusiasm for buying, but the good news was that there was no real selling after […]
By Ben LevisohnLeerink’s Howard Liang and team think 2015 will be another good year for biotech stocks like Gilead Sciences (GILD), Celgene (CELG), Amgen (AMGN ) and Alexion Pharmaceuticals (ALXN). They explain why:
Boston Globe via Getty Images
Biotech fundamentals appear strong, and could attract and broaden investor interest in the sector. Ongoing and upcoming product launches could be among the fastest […]
It was an impressive turnaround on Tuesday for the stock market as, after Monday’s drop, the short-term momentum appeared to be turning negative. Of course, to keep the positive “Mo” going, we need to see further gains Wednesday. A drop back below Monday’s lows will turn the focus back on the downside.The S&P futures are flat in early trading and […]
